<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Lab Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Ann Lab Med</journal-id>
      <journal-id journal-id-type="publisher-id">ALM</journal-id>
      <journal-title-group>
        <journal-title>Annals of Laboratory Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">2234-3806</issn>
      <issn pub-type="epub">2234-3814</issn>
      <publisher>
        <publisher-name>The Korean Society for Laboratory Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23483615</article-id>
      <article-id pub-id-type="pmc">3589642</article-id>
      <article-id pub-id-type="doi">10.3343/alm.2013.33.2.145</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Clinical Microbiology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Rothia mucilaginosa</italic> Pneumonia Diagnosed by Quantitative Cultures and Intracellular Organisms of Bronchoalveolar Lavage in a Lymphoma Patient</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Eun-Jung</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>Heungsup</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Sook-Ja</given-names>
          </name>
          <degrees>M.T.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Mi-Na</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Sang-Oh</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.</aff>
      <aff id="A2"><label>2</label>Department of Internal Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.</aff>
      <author-notes>
        <corresp>Corresponding author: Mi-Na Kim. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. Tel: +82-2-3010-4513, Fax: +82-2-478-0884, <email>mnkim@amc.seoul.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <volume>33</volume>
      <issue>2</issue>
      <fpage>145</fpage>
      <lpage>149</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>8</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>24</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Korean Society for Laboratory Medicine.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><italic>Rothia mucilaginosa</italic> is a gram-positive coccus of the family Micrococcaceae. <italic>R. mucilaginosa</italic> is considered a part of the normal flora of the human oropharynx and upper respiratory tract and lower respiratory tract infections attributable to <italic>R. mucilaginosa</italic> are not frequent. We present a case of pneumonia, in which the <italic>R. mucilaginosa</italic> infection was diagnosed by quantitative cultures of a bronchoalveolar lavage (BAL) specimen. A 46-yr-old woman with B lymphoblastic lymphoma was admitted to the hospital for scheduled chemotherapy. Her chest computed tomography (CT) scan revealed bilateral multifocal nodular and patchy consolidation in both lungs. Investigation of the BAL specimen revealed that 7% of leukocytes had intracellular gram-positive cocci. The quantitative cultures of the BAL specimen grew mucoid, non-hemolytic, and grayish convex colonies on blood agar at a count of approximately 200,000 colony-forming units/mL. The colonies were identified as <italic>R. mucilaginosa</italic>. The patient was empirically treated with levofloxacin for 7 days, after which findings on the chest radiograph and CT scan improved. She was discharged with improvement on hospital day 46. To our knowledge, this is the first report of <italic>R. mucilaginosa</italic> pneumonia diagnosed in Korea. Quantitative culture of BAL specimen and examination of intracellular organisms are crucial for assessing the clinical significance of <italic>R. mucilaginosa</italic> recovered from the lower respiratory tract.</p>
      </abstract>
      <kwd-group>
        <kwd>
          <italic>Rothia mucilaginosa</italic>
        </kwd>
        <kwd>Low respiratory tract infections</kwd>
        <kwd>Pneumonia</kwd>
        <kwd>Quantitative culture</kwd>
        <kwd>Intracellular organisms</kwd>
        <kwd>Bronchoalveolar lavage</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p><italic>Rothia mucilaginosa</italic>, previously <italic>Stomatococcus mucilaginosus</italic>, is an aerobic, gram-positive coccus belonging to the family Micrococcaceae. It is found in the oropharynx and upper respiratory tract as part of the normal flora [<xref ref-type="bibr" rid="B1">1</xref>] and was first isolated from an endocarditis patient in 1978 [<xref ref-type="bibr" rid="B2">2</xref>]. It is considered an opportunistic pathogen, most often seen in immunocompromised patients, but it is also (less frequently) observed in immunocompetent subjects [<xref ref-type="bibr" rid="B3">3</xref>]. There are reports of <italic>R. mucilaginosa</italic> as a cause of bacteremia, central nervous system infection, meningitis, peritonitis, osteomyelitis, cervical necrotizing fasciitis, endophthalmitis, and endocarditis [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]. Only a dozen cases of lower respiratory tract infection caused by <italic>R. mucilaginosa</italic> have been diagnosed by recovery of <italic>R. mucilaginosa</italic> from the bronchoscopic, blood, or sputum specimens [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. <italic>R. mucilaginosa</italic> is generally considered to be a contaminant in respiratory tract infection specimens. Therefore, for <italic>R. mucilaginosa</italic> to be confirmed as a cause of a lower respiratory tract infection, the diagnostic specimen must be minimally contaminated. In this study, we report a case of pneumonia due to <italic>R. mucilaginosa</italic> that was diagnosed by quantitative cultures and visualization of intracellular organisms from a bronchoalveolar lavage (BAL) specimen from a lymphoma patient.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 46-yr-old woman was diagnosed with B lymphoblastic lymphoma stage IVB on December 6, 2011. She achieved complete remission after 2 courses of chemotherapy that comprised vincristine, prednisolone, daunorubicin, and L-asparaginase. In January 2012, she was treated with ciprofloxacin because of neutropenia and bacteremia caused by <italic>Bacillus cereus</italic>. On February 18, 2012, fever and diarrhea developed after the second course of chemotherapy, and she received empirical treatment with vancomycin for 4 days and meropenem for 8 days. On February 22, 2012, <italic>Clostridium difficile</italic>-associated diarrhea developed, and oral metronidazole was administered for 7 days. The patient was admitted to the hospital on March 6, 2012 for scheduled chemotherapy.</p>
      <p>On admission, her body temperature was 36.0&#x2103;, pulse rate was 101/min, respiration rate was 20/min, and blood pressure was 111/76 mmHg. Complete blood cell count showed a hemoglobin level of 9.6 g/dL, a white blood cell count of 7.5&#xD7;10<sup>9</sup>/L (with 1.0% myelocytes, 2.0% metamyelocytes, and 54.0% neutrophils), and a platelet count of 351&#xD7;10<sup>9</sup>/L. The C-reactive protein level was elevated at 0.1 mg/dL. The chest radiograph and computed tomography (CT) scan revealed multifocal nodular and patchy consolidation in both the lungs that suggested atypical pneumonia or bronchiolitis obliterans organizing pneumonia secondary to drug reaction or viral infection (<xref ref-type="fig" rid="F1">Fig. 1</xref>). The abdominal CT scan revealed a liver abscess in liver segment III. Due to suspicion of community-acquired atypical pneumonia, she was treated empirically with levofloxacin for 7 days and underwent bronchoscopy on hospital day (HD) 3.</p>
      <p>The BAL specimen was used for the quantitative culture, and a gram-stained smear was prepared with a cytospin centrifuge. Microscopy of the smear revealed a white blood cell count of 10-25/low power field (LPF), an epithelial cell count of &lt;1/LPF, and 7% of leukocytes contained intracellular organisms (ICOs) (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Acid-fast bacilli stain and culture, <italic>Mycobacterium tuberculosis</italic> PCR, respiratory virus PCR, and fungus culture of the BAL specimen were all negative, but the patient was positive for rhinovirus. The quantitative cultures of the BAL specimen on blood agar plates and chocolate agar plates grew predominantly mucoid, non-hemolytic, and grayish convex colonies after 2 days of incubation at 37&#x2103; and 5% CO<sub>2</sub> (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). The colony counts were approximately 200,000 colony-forming units (CFU)/mL. The colonies were sticky on the agar surface. Gram staining of the colonies showed gram-positive cocci of the same morphology as those that appeared on the direct smear (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). The bacterium was identified as <italic>R. mucilaginosa</italic> using an API Staph Identification Panel (bioM&#xE9;rieux SA, Marcy 1'Etoile, France); the profile number was 6310134 at a probability of 99.9%. The 16S rRNA gene sequencing of this isolate showed an identity of 99.7% (1,325 of 1,329 bp) with <italic>R. mucilaginosa</italic> ATCC 25296<sup>T</sup> (GenBank accession no. ACVO01000020). The isolate also had 98.3% homology with <italic>R. dentocariosa</italic> ATCC 17931<sup>T</sup> (GenBank accession no. CP002280).</p>
      <p>The minimum inhibitory concentrations (MICs) for this isolate were determined using a MicroScan MICroSTREP plus 1 panel (Siemens Healthcare Diagnostics, West Sacramento, CA, USA). This broth microdilution susceptibility test was performed with cation-adjusted Mueller-Hinton agar, supplemented with 3% lysed horse blood (Siemens Healthcare Diagnostics) [<xref ref-type="bibr" rid="B10">10</xref>]. MICs of the tested antimicrobials were 0.06 &#xB5;g/mL for penicillin, 0.06 &#xB5;g/mL for ampicillin, &#x2264;0.5/0.25 &#xB5;g/mL for amoxicillin/clavulanate, &#x2264;0.25 &#xB5;g/mL for azithromycin, &gt;0.5 &#xB5;g/mL for clindamycin, &#x2264;0.06 &#xB5;g/mL for erythromycin, 2 &#xB5;g/mL for chloramphenicol, &#x2264;0.25 &#xB5;g/mL for ceftriaxone, 1 &#xB5;g/mL for cefaclor, &#x2264;0.25 &#xB5;g/mL for cefotaxime, 2 &#xB5;g/mL for cefepime, &#x2264;0.25 &#xB5;g/mL for cefuroxime, &gt;4 &#xB5;g/mL for levofloxacin, &gt;0.5 &#xB5;g/mL for meropenem, 0.5/9.5 &#xB5;g/mL for trimethoprim/sulfamethoxazole, 1 &#xB5;g/mL for tetracycline, and 1 &#xB5;g/mL for vancomycin. The MICs of other antimicrobials were determined using the E-test (AB Biodisk, Solna, Sweden) on Mueller-Hinton agar supplemented with 5% sheep blood; the MICs were 12 &#xB5;g/mL for gentamicin, 0.19 &#xB5;g/mL for imipenem, and 0.5 &#xB5;g/mL for piperacillin/tazobactam.</p>
      <p>Intravenous levofloxacin treatment was stopped on HD 7 because of the possibility of leukopenia induced by antibiotic therapy. The chest radiograph obtained at this time showed a reduction in the multifocal nodular and patchy consolidation in both lungs. Ampicillin/sulbactam and ciprofloxacin were started due to the organizing liver abscess. On HD 30, the third course of chemotherapy was started and completed without complications. The patient was discharged on HD 46 with complete resolution of pneumonia and liver abscess.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In this study, we present a case of pneumonia, in which <italic>R. mucilaginosa</italic> was the only significant organism recovered from the BAL culture. This intracellular organism was considered to be the causative pathogen of the pneumonia by combined analysis of the quantitative culture and visualization of ICOs. The patient' s chest radiograph and CT scan indicated likely atypical pneumonia, and the BAL specimen was also positive for rhinovirus. Therefore rhinovirus could not be ruled out as a causative agent of pneumonia. However, considering the purulent BAL specimen, we believed that the bacteria played at least a partially pathogenic role, and the patient was treated with antimicrobial therapy.</p>
      <p>The predominant growth of <italic>R. mucilaginosa</italic> in the BAL specimens with rare epithelial cells was not likely due to contamination by the normal oropharyngeal flora. There have been fewer than 20 cases of lower respiratory tract infection caused by <italic>R. mucilaginosa</italic> reported worldwide [<xref ref-type="bibr" rid="B9">9</xref>], and the clinical manifestation of disease have ranged from mild bronchitis to pneumonia or recurrent lung abscesses [<xref ref-type="bibr" rid="B6">6</xref>]. However, it is difficult to determine the clinical significance of <italic>R. mucilaginosa</italic> when it is found in respiratory specimens. The diagnosis of pneumonia caused by <italic>R. mucilaginosa</italic> requires at least a culture from the bronchoscopic specimen [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B9">9</xref>]. In this case, the quantitative cultures from the BAL specimen provided more than 10<sup>5</sup> CFU/mL, which was enough to diagnose the causative agents of pneumonia [<xref ref-type="bibr" rid="B11">11</xref>]. These culture findings supported <italic>R. mucilaginosa</italic> as a true pathogen.</p>
      <p>In this case, analysis of the direct smear revealed significant numbers of macrophages and neutrophils engulfing gram-positive cocci in clusters as ICOs. The quantitative cultures of the BAL specimen grew organisms with the same morphology as these ICOs. Detecting ICOs in the BAL fluid is an early indication of an infectious pulmonary process [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>], and a cytologic study of the BAL specimen to identify ICOs would allow us to determine the causative agents of nosocomial pneumonia [<xref ref-type="bibr" rid="B14">14</xref>]. Quantitative cultures of the BAL specimens show moderate correlation with the percentage of ICOs in the specimen, which in turn correlates with the lung bacterial burden [<xref ref-type="bibr" rid="B13">13</xref>]. The percentage of neutrophils that contain ICOs is higher in patients with pneumonia than in those without pneumonia [<xref ref-type="bibr" rid="B14">14</xref>]; the cut-off varies from 1% to more than 20% [<xref ref-type="bibr" rid="B14">14</xref>]. The Centers for Disease Control and Prevention/National Healthcare Safety Network recommends 5% as a critical value for pneumonia diagnosis [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      <p>There are no previous reports of pneumonia due to <italic>R. mucilaginosa</italic> that was diagnosed by quantitative analysis of BAL cultures and ICOs. We identified <italic>R. mucilaginosa</italic> using the API Staph Identification Panel (bioM&#xE9;rieux SA). Several other commercial kits are available for the identification of <italic>R. mucilaginosa</italic>; however, their accuracy for this rarely isolated species has been questioned [<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B16">16</xref>]. Because <italic>R. mucilaginosa</italic> is not a common pathogen in respiratory specimens, we confirmed the identification by 16S rRNA gene sequencing. The morphology of this organism was consistent with its identification as <italic>R. mucilaginosa</italic>, which is an encapsulated gram-positive coccus found in pairs, clusters, and tetrads, with colonies that are mucoid, rubbery, or sticky in consistency and adherent to agar [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>].</p>
      <p>The isolate was resistant to gentamicin, clindamycin, and levofloxacin. <italic>R. mucilaginosa</italic> has a variety of antimicrobial susceptibilities [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. Although the interpretation of antimicrobial susceptibility testing is not standardized, third-generation cephalosporins, vancomycin, high-dose ampicillin, rifampin, and chloramphenicol are consistently active against this bacterium [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B17">17</xref>]. <italic>R. mucilaginosa</italic> has a broad range of susceptibility to other agents such as penicillin, clindamycin, and erythromycin [<xref ref-type="bibr" rid="B17">17</xref>]. Therefore, the susceptibility pattern of this isolate was generally consistent with that of <italic>R. mucilaginosa</italic> from previous reports [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. When the MIC breakpoints for <italic>Corynebacterium</italic> spp. were applied in this case [<xref ref-type="bibr" rid="B10">10</xref>], the organism was susceptible to penicillin, clindamycin, erythromycin, ceftriaxone, cefotaxime, cefepime, meropenem, trimethoprim/sulfamethoxazole, tetracycline, vancomycin, and imipenem. The other antimicrobials were interpreted according to the MIC breakpoints for <italic>Staphylococcus</italic> spp. [<xref ref-type="bibr" rid="B22">22</xref>]; the pathogen was susceptible to ampicillin, amoxicillin/clavulanate, azithromycin, chloramphenicol, cefuroxime, and piperacillin/tazobactam, and resistant to levofloxacin. We can speculate on the emergence of acquired resistance to fluoroquinolones because the patient had a history of ciprofloxacin treatment. There are previous reports of emerging resistance of <italic>R. mucilaginosa</italic> to ciprofloxacin [<xref ref-type="bibr" rid="B18">18</xref>] and trimethoprim/sulfamethoxazole [<xref ref-type="bibr" rid="B5">5</xref>] in association with prophylactic antimicrobial therapy.</p>
      <p>The variable susceptibility of <italic>R. mucilaginosa</italic> to &#x3B2;-lactams, aminoglycosides, macrolides, and fluoroquinolones dictates that the choice of antimicrobial agents should be guided by individual susceptibility tests in cases of severe infection. Rifampin, penicillin, ciprofloxacin, gentamicin, and clarithromycin have been previously used to treat <italic>R. mucilaginosa</italic> pneumonia [<xref ref-type="bibr" rid="B6">6</xref>]. Although in our case the isolate was resistant to levofloxacin, the pneumonia improved after levofloxacin therapy. Levofloxacin can be concentrated in respiratory tissues and intracellular compartments [<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>] and is the treatment of choice for community-acquired pneumonia. In our case, levofloxacin may have been more active than <italic>in vitro</italic> susceptibility results on ICOs would have led us to expect. Outcomes of <italic>R. mucilaginosa</italic> pneumonia treated with levofloxacin are generally favorable, but non-attributable mortality has been found in patients with serious underlying disease [<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B9">9</xref>].</p>
      <p>In conclusion, this is the first description of pneumonia caused by <italic>R. mucilaginosa</italic> in Korea. This case indicates that quantitative analysis of BAL culture and ICOs are useful for diagnosing pneumonia caused by <italic>R. mucilaginosa</italic>.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>No potential conflicts of interest relevant to this article were reported.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>von Eiff</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Becker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Christof von</surname>
              <given-names>EIFF</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Carroll</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Versalovic</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title><italic>Staphylococcus</italic>, <italic>Micrococcus</italic> and other catalase-positive cocci</article-title>
          <source>Manual of clinical microbiology</source>
          <year>2011</year>
          <edition>10th ed</edition>
          <publisher-loc>Washington DC</publisher-loc>
          <publisher-name>American Society for Microbiology</publisher-name>
          <fpage>308</fpage>
          <lpage>330</lpage>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubin</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lyons</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Murcia</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Endocarditis associated with cardiac catheterization due to a Gram-positive coccus designated <italic>Micrococcus mucilaginosus incertae sedis</italic></article-title>
          <source>J Clin Microbiol</source>
          <year>1978</year>
          <volume>7</volume>
          <fpage>546</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="pmid">670378</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Faiad</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Singh</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Narasimhan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mendez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shama</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nassar</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title><italic>Rothia mucilaginosa</italic> life threatening infections in non-neutropenic hosts</article-title>
          <source>Open J Intern Med</source>
          <year>2011</year>
          <volume>1</volume>
          <fpage>68</fpage>
          <lpage>71</lpage>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ascher</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Zbick</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Infections due to <italic>Stomatococcus mucilaginosus</italic>: 10 cases and review</article-title>
          <source>Rev Infect Dis</source>
          <year>1991</year>
          <volume>13</volume>
          <fpage>1048</fpage>
          <lpage>1052</lpage>
          <pub-id pub-id-type="pmid">1775836</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trevi&#xF1;o</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garc&#xED;a-Zabarte</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Quint&#xE1;s</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Varela</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>L&#xF3;pez-Paz</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Jato</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Stomatococcus mucilaginosus</italic> septicemia in a patient with acute lymphoblastic leukaemia</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>505</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">9764554</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Korsholm</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Haahr</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Prag</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Eight cases of lower respiratory tract infection caused by <italic>Stomatococcus mucilaginosus</italic></article-title>
          <source>Scand J Infect Dis</source>
          <year>2007</year>
          <volume>39</volume>
          <fpage>913</fpage>
          <lpage>917</lpage>
          <pub-id pub-id-type="pmid">17886126</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lambotte</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Debord</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Soler</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Rou&#xE9;</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Pneumonia due to <italic>Stomatococcus mucilaginosus</italic> in an AIDS patient: case report and literature review</article-title>
          <source>Clin Microbiol Infect</source>
          <year>1999</year>
          <volume>5</volume>
          <fpage>112</fpage>
          <lpage>114</lpage>
          <pub-id pub-id-type="pmid">11856231</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xE1;nchez-Carrillo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cercenado</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cibri&#xE1;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bouza</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title><italic>Stomatococcus mucilaginosus</italic> pneumonia in a liver-transplant patient</article-title>
          <source>Clin Microbiol Newsl</source>
          <year>1995</year>
          <volume>16</volume>
          <fpage>150</fpage>
          <lpage>151</lpage>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunniffe</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Mallia</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Alcock</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title><italic>Stomatococcus mucilaginosus</italic> lower respiratory tract infection in a patient with AIDS</article-title>
          <source>J Infect</source>
          <year>1994</year>
          <volume>29</volume>
          <fpage>327</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="pmid">7884227</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="book">
          <collab>Clinical Laboratory Standards Institute</collab>
          <source>Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline 2nd ed, M45-A2</source>
          <year>2010</year>
          <publisher-loc>Wayne, PA</publisher-loc>
          <publisher-name>Clinical Laboratory Standards Institute</publisher-name>
          <fpage>18</fpage>
          <lpage>19</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cantral</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Tape</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Reed</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Spurzem</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Rennard</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Quantitative culture of bronchoalveolar lavage fluid for the diagnosis of bacterial pneumonia</article-title>
          <source>Am J Med</source>
          <year>1993</year>
          <volume>95</volume>
          <fpage>601</fpage>
          <lpage>607</lpage>
          <pub-id pub-id-type="pmid">8259777</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Allaouchiche</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jaumain</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Dumontet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Motin</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Early diagnosis of ventilator-associated pneumonia. Is it possible to define a cutoff value of infected cells in BAL fluid?</article-title>
          <source>Chest</source>
          <year>1996</year>
          <volume>110</volume>
          <fpage>1558</fpage>
          <lpage>1565</lpage>
          <pub-id pub-id-type="pmid">8989077</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Torres</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>El-Ebiary</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>F&#xE1;bregas</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;ilez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>de la Bellacasa</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Hern&#xE1;ndez</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Value of intracellular bacteria detection in the diagnosis of ventilator associated pneumonia</article-title>
          <source>Thorax</source>
          <year>1996</year>
          <volume>51</volume>
          <fpage>378</fpage>
          <lpage>384</lpage>
          <pub-id pub-id-type="pmid">8733489</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sol&#xE9;-Viol&#xE1;n</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez de Castro</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rey</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n-Gonz&#xE1;lez</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Cabrera-Navarro</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Usefulness of microscopic examination of intracellular organisms in lavage fluid in ventilator-associated pneumonia</article-title>
          <source>Chest</source>
          <year>1994</year>
          <volume>106</volume>
          <fpage>889</fpage>
          <lpage>894</lpage>
          <pub-id pub-id-type="pmid">8082373</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horan</surname>
              <given-names>TC</given-names>
            </name>
            <name>
              <surname>Andrus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dudeck</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting</article-title>
          <source>Am J Infect Control</source>
          <year>2008</year>
          <volume>36</volume>
          <fpage>309</fpage>
          <lpage>332</lpage>
          <pub-id pub-id-type="pmid">18538699</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Garcia</surname>
              <given-names>LS</given-names>
            </name>
            <name>
              <surname>Isenberg</surname>
              <given-names>HD</given-names>
            </name>
          </person-group>
          <source>Clinical microbiology procedures handbook</source>
          <year>2010</year>
          <volume>1</volume>
          <edition>3rd ed</edition>
          <publisher-loc>Washington DC</publisher-loc>
          <publisher-name>ASM Press</publisher-name>
          <comment>3.11.2.173.11.2.20-7</comment>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Eiff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herrmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial susceptibilities of <italic>Stomatococcus mucilaginosus</italic> and of <italic>Micrococcus</italic> spp</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>1995</year>
          <volume>39</volume>
          <fpage>268</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="pmid">7695321</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>von Eiff</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>In vitro activity of ciprofloxacin, ofloxacin, and levofloxacin against <italic>Micrococcus</italic> species and <italic>Stomatococcus mucilaginosus</italic> isolated from healthy subjects and neutropenic patients</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>890</fpage>
          <lpage>892</lpage>
          <pub-id pub-id-type="pmid">10052561</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skogen</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Kolmannskog</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bergh</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Bactericidal activity in cerebrospinal fluid by treating meningitis caused by <italic>Stomatococcus mucilaginosus</italic> with rifampicin, cefotaxime and vancomycin in a neutropenic child</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>39</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">11284946</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McWhinney</surname>
              <given-names>PH</given-names>
            </name>
            <name>
              <surname>Kibbler</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hoffbrand</surname>
              <given-names>AV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>Stomatococcus mucilaginosus</italic>: an emerging pathogen in neutropenic patients</article-title>
          <source>Clin Infect Dis</source>
          <year>1992</year>
          <volume>14</volume>
          <fpage>641</fpage>
          <lpage>646</lpage>
          <pub-id pub-id-type="pmid">1562654</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chomarat</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vital</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Flandrois</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Susceptibility to aminoglycosides of 63 strains of <italic>Stomatococcus mucilaginosus</italic> isolated from sputum</article-title>
          <source>Zentralbl Bakteriol</source>
          <year>1991</year>
          <volume>276</volume>
          <fpage>63</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">1789902</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="book">
          <collab>Clinical Laboratory Standards Institute</collab>
          <source>Performance standards for antimicrobial susceptibility testing. Twenty-Second Informational supplement,M100-S22</source>
          <year>2012</year>
          <publisher-loc>Wayne, PA</publisher-loc>
          <publisher-name>Clinical Laboratory Standards Institute</publisher-name>
          <fpage>70</fpage>
          <lpage>79</lpage>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Capitano</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Mattoes</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>O'Brien</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Braman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sutherland</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults</article-title>
          <source>Chest</source>
          <year>2004</year>
          <volume>125</volume>
          <fpage>965</fpage>
          <lpage>973</lpage>
          <pub-id pub-id-type="pmid">15006955</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhanel</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Ennis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vercaigne</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Walkty</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gin</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Embil</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A critical review of the fluoroquinolones: focus on respiratory infections</article-title>
          <source>Drugs</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>13</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">11790155</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>(A) Chest radiograph showing bilateral ground glass opacity and patchy nodular opacity in both lungs. (B) Axial contrast-enhanced chest computed tomography image showing multifocal nodular and patchy consolidation in both lungs.</p>
      </caption>
      <graphic xlink:href="alm-33-145-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Microscopic images of gram-stained smears of the bronchoalveolar lavage specimens that were prepared with a cytospin centrifuge (Gram stain, &#xD7;1,000). Images show clusters of neutrophils containing intracellular gram-positive cocci. Arrowheads indicate the neutrophil-containing intracellular gram-positive cocci.</p>
      </caption>
      <graphic xlink:href="alm-33-145-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>(A) Image of <italic>Rothia mucilaginosa</italic> grown on a blood agar plate showing mucoid, grayish colonies after incubation at 37&#x2103; for 48 hr. (B) Microscopic image of the cultured isolates showing clusters of gram-positive cocci (Gram stain, &#xD7;1,000).</p>
      </caption>
      <graphic xlink:href="alm-33-145-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
